FDA Panel Votes Against Recommending Novartis Gout Treatment - Wall Street Journal

InPharm

FDA Panel Votes Against Recommending Novartis Gout Treatment Wall Street Journal Ilaris treats gout symptoms "without improving the root cause," said FDA clinical researcher Larissa Lapteva at the conclusion of the FDA presentation. Novartis proposed the drug for treatment of patients suffering from "gouty arthritis attacks. ... FDA Panel Votes Against Approval Of Novartis' Gouty Arthritis DrugRTT News Novartis says panel votes against arthritis drugBusinessWeek FDA panel endorses efficacy but not safety of Novartis drug ACZ885 for gouty ...Reuters (press release) Genetic Engineering News -Arthritis Today -Zacks.com all 65 news articles »

Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in ... - PR Newswire (press release)

Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in ... PR Newswire (press release) In addition to ARCALYST ® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in Phase III clinical trials for the potential treatment of gout, diseases of the eye (wet age-related macular ... and more »

Panchkarma therapy revives Ayush centre - Times of India

Panchkarma therapy revives Ayush centre Times of India The centre now gets 30 patients suffering from arthritis, backache, gout, cervical spondylosis and sciatica every day. The hospital authorities said the residents were apparently not aware of the centre earlier. According to doctors, the maximum number ...

Casey admits health concern as Lawrie hits rock bottom - The Independent

Casey admits health concern as Lawrie hits rock bottom The Independent "I thought it might have been a bite from some insect where I live in Arizona. Then we thought it might be gout, but both things were ruled out. It might even be early-stage arthritis, but whatever it is it needs to be sorted out soon. ...